跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18,284 条关于
“VEGFR tyrosine kinase inhibitors”
全部
18,284
临床试验
9,226
药物
3,776
机构
22
资讯
5,260
去年
Olverembatinib Shows Promise in TKI-Resistant CML and Ph+ ALL
2个月前
EGFR-TKIs Pose Highest Cardiovascular Risk Among Tyrosine Kinase Inhibitors, Meta-Analysis Finds
9个月前
Tyrosine Kinase Inhibitors and Gene Therapies Show Promise for Wet AMD Treatment
6个月前
HIF-2α Inhibitor Casdatifan Demonstrates 15-Month Progression-Free Survival in Advanced Kidney Cancer
去年
Ruxolitinib Plus TKI Therapy Shows Promise in Chronic Myeloid Leukemia
2年前
OncoHost's PROphet Platform Shows Promise in Predicting Outcomes for Renal Cell Carcinoma
上个月
Non-Tyrosine Kinase Inhibitors Market to Reach USD 18.7 Billion by 2036, Driven by Biomarker-Linked Oncology Approvals
去年
ESK981 Plus Nivolumab Fails to Show Antitumor Activity in Metastatic Castration-Resistant Prostate Cancer
去年
JAK Inhibitor Pipeline Shows Promise for Autoimmune and Inflammatory Diseases
6年前
CDK4/6 Inhibitors Plus Endocrine Therapy Improves Survival in HR+/HER2- Advanced Breast Cancer
第 1 页，共 526 页
上一页
下一页
